|
|||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
Sunday, June 22
by
All About MS
on Sun 22 Jun 2008 07:42 AM CST
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a cell therapy development and commercialization company, announced favourable safety and efficacy data for Tovaxin®, the Company's investigational T-cell vaccination more »
by
All About MS
on Sun 22 Jun 2008 12:00 AM CST
Peptimmune, Inc. a privately held biotechnology company, announced that physicians have treated the first participant in a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary more »
|
||